Penghua Fang Selected Research

Galanin

1/2023	Cardioprotective effects of neuropeptide galanin: Focusing on its roles against diabetic heart.
5/2022	Time-restricted feeding prevents metabolic diseases through the regulation of galanin/GALR1 expression in the hypothalamus of mice.
10/2021	Emerging roles of kisspeptin/galanin in age-related metabolic disease.
1/2021	A promising biomarker of elevated galanin level in hypothalamus for osteoporosis risk in type 2 diabetes mellitus.
12/2020	Beneficial effects of galanin system on diabetic peripheral neuropathic pain and its complications.
1/2020	Galanin peptide family regulation of glucose metabolism.
3/2019	Galanin expression is down-regulated in patients with gastric cancer.
1/2019	Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1α/GLUT4 axis-mediated glucose consumption.
10/2018	Central galanin receptor 2 mediates galanin action to promote systemic glucose metabolism of type 2 diabetic rats.
12/2017	Serum Galanin Concentration is Increased in Subjects with Impaired Glucose Tolerance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Penghua Fang Research Topics

Disease

37	Insulin Resistance 05/2024 - 06/2011
21	Obesity 05/2024 - 08/2012
14	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2012
14	Body Weight (Weight, Body) 01/2022 - 08/2011
13	Hyperglycemia 01/2023 - 01/2016
9	Glucose Intolerance 02/2022 - 10/2012
5	Metabolic Diseases (Metabolic Disease) 01/2024 - 10/2021
3	Inflammation (Inflammations) 05/2024 - 01/2022
3	Pain (Aches) 12/2020 - 06/2013
3	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2015 - 06/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 05/2024 - 01/2022
2	Non-alcoholic Fatty Liver Disease 01/2022 - 03/2020
2	Wounds and Injuries (Trauma) 01/2022 - 12/2015
2	Osteoporosis 01/2021 - 11/2018
2	Dyslipidemias (Dyslipidemia) 02/2020 - 10/2012
2	Hyperlipidemias (Hyperlipidemia) 02/2020 - 08/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 09/2015
2	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 12/2013
2	Hypertension (High Blood Pressure) 10/2012 - 08/2012
1	Diabetic Cardiomyopathies 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Fatty Liver 07/2022
1	Infections 01/2022
1	Diabetic Foot 01/2022
1	Ulcer 01/2022
1	Pressure Ulcer (Bedsore) 01/2022
1	Bone Resorption 11/2021
1	Neuralgia (Stump Neuralgia) 12/2020
1	Alcoholic Fatty Liver 02/2020
1	Stomach Neoplasms (Stomach Cancer) 03/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2017
1	Psychological Trauma 01/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2016
1	Diarrhea 01/2016
1	Cardiomyopathies (Cardiomyopathy) 03/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012
1	Overweight 08/2012

Drug/Important Bio-Agent (IBA)

32	GalaninIBA 01/2023 - 06/2011
28	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2013
10	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018 - 06/2011
9	Insulin (Novolin)FDA Link 02/2022 - 03/2013
8	NeuropeptidesIBA 01/2021 - 03/2013
7	baicalinIBA 05/2024 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2014
5	Peptides (Polypeptides)IBA 10/2021 - 10/2012
5	Blood Glucose (Blood Sugar)IBA 03/2020 - 12/2014
4	AdipokinesIBA 01/2023 - 01/2022
4	Messenger RNA (mRNA)IBA 05/2018 - 12/2014
4	Galanin Receptors (Galanin Receptor)IBA 01/2017 - 03/2013
3	AdiponectinIBA 07/2022 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2014
3	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2019
3	Hormones (Hormone)IBA 12/2015 - 06/2011
2	Type 2 Galanin ReceptorIBA 01/2023 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 10/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 03/2020
2	baicaleinIBA 02/2020 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2018 - 05/2014
2	Type 1 Galanin ReceptorIBA 01/2018 - 01/2016
2	alarinIBA 01/2015 - 12/2014
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 12/2014 - 01/2014
1	NEDD8 ProteinIBA 01/2024
1	MyokinesIBA 01/2023
1	AntioxidantsIBA 01/2022
1	Protons (Proton)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	LeptinIBA 01/2022
1	SodiumIBA 01/2022
1	CollagenIBA 01/2022
1	KisspeptinsIBA 10/2021
1	Sirtuin 1IBA 01/2021
1	LipidsIBA 03/2020
1	San-HuangIBA 03/2020
1	celastrolIBA 01/2019
1	Alkaline PhosphataseIBA 11/2018
1	Tartrate-Resistant Acid PhosphataseIBA 11/2018
1	OsteocalcinIBA 11/2018
1	Estrogens (Estrogen)FDA Link 11/2018
1	BuffersIBA 01/2017
1	human MIRN29B1 microRNAIBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Glucose Transporter Type 4IBA 12/2014
1	alarin 6-25CysIBA 12/2014
1	2- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA 12/2014
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 12/2014
1	GhrelinIBA 01/2014
1	Galanin-Like PeptideIBA 01/2014
1	LigandsIBA 03/2013
1	CholesterolIBA 08/2012

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 01/2022
1	Therapeutics 08/2012